-
Je něco špatně v tomto záznamu ?
The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group
M. Koziolek, S. Alcaro, P. Augustijns, AW. Basit, M. Grimm, B. Hens, CL. Hoad, P. Jedamzik, CM. Madla, M. Maliepaard, L. Marciani, A. Maruca, N. Parrott, P. Pávek, CJH. Porter, C. Reppas, D. van Riet-Nales, J. Rubbens, M. Statelova, NL....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, přehledy
- MeSH
- aplikace orální MeSH
- biologická dostupnost MeSH
- farmakokinetika MeSH
- gastrointestinální absorpce fyziologie MeSH
- gastrointestinální trakt fyziologie MeSH
- interakce mezi potravou a léky fyziologie MeSH
- intestinální absorpce MeSH
- lidé MeSH
- uvolňování léčiv fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Evropa MeSH
The simultaneous intake of food and drugs can have a strong impact on drug release, absorption, distribution, metabolism and/or elimination and consequently, on the efficacy and safety of pharmacotherapy. As such, food-drug interactions are one of the main challenges in oral drug administration. Whereas pharmacokinetic (PK) food-drug interactions can have a variety of causes, pharmacodynamic (PD) food-drug interactions occur due to specific pharmacological interactions between a drug and particular drinks or food. In recent years, extensive efforts were made to elucidate the mechanisms that drive pharmacokinetic food-drug interactions. Their occurrence depends mainly on the properties of the drug substance, the formulation and a multitude of physiological factors. Every intake of food or drink changes the physiological conditions in the human gastrointestinal tract. Therefore, a precise understanding of how different foods and drinks affect the processes of drug absorption, distribution, metabolism and/or elimination as well as formulation performance is important in order to be able to predict and avoid such interactions. Furthermore, it must be considered that beverages such as milk, grapefruit juice and alcohol can also lead to specific food-drug interactions. In this regard, the growing use of food supplements and functional food requires urgent attention in oral pharmacotherapy. Recently, a new consortium in Understanding Gastrointestinal Absorption-related Processes (UNGAP) was established through COST, a funding organisation of the European Union supporting translational research across Europe. In this review of the UNGAP Working group "Food-Drug Interface", the different mechanisms that can lead to pharmacokinetic food-drug interactions are discussed and summarised from different expert perspectives.
Medicines Evaluation Board in the Netherlands PKPD Department Utrecht the Netherlands
Medicines Evaluation Board in the Netherlands Quality Department Utrecht the Netherlands
University of Zagreb Faculty of Pharmacy and Biochemistry A Kovačića 1 10000 Zagreb Croatia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044889
- 003
- CZ-PrNML
- 005
- 20200114083039.0
- 007
- ta
- 008
- 200109s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejps.2019.04.003 $2 doi
- 035 __
- $a (PubMed)30974173
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Koziolek, Mirko $u Department of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, Center of Drug Absorption and Transport, Felix-Hausdorff-Str. 3, D-17487 Greifswald, Germany.
- 245 14
- $a The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group / $c M. Koziolek, S. Alcaro, P. Augustijns, AW. Basit, M. Grimm, B. Hens, CL. Hoad, P. Jedamzik, CM. Madla, M. Maliepaard, L. Marciani, A. Maruca, N. Parrott, P. Pávek, CJH. Porter, C. Reppas, D. van Riet-Nales, J. Rubbens, M. Statelova, NL. Trevaskis, K. Valentová, M. Vertzoni, DV. Čepo, M. Corsetti,
- 520 9_
- $a The simultaneous intake of food and drugs can have a strong impact on drug release, absorption, distribution, metabolism and/or elimination and consequently, on the efficacy and safety of pharmacotherapy. As such, food-drug interactions are one of the main challenges in oral drug administration. Whereas pharmacokinetic (PK) food-drug interactions can have a variety of causes, pharmacodynamic (PD) food-drug interactions occur due to specific pharmacological interactions between a drug and particular drinks or food. In recent years, extensive efforts were made to elucidate the mechanisms that drive pharmacokinetic food-drug interactions. Their occurrence depends mainly on the properties of the drug substance, the formulation and a multitude of physiological factors. Every intake of food or drink changes the physiological conditions in the human gastrointestinal tract. Therefore, a precise understanding of how different foods and drinks affect the processes of drug absorption, distribution, metabolism and/or elimination as well as formulation performance is important in order to be able to predict and avoid such interactions. Furthermore, it must be considered that beverages such as milk, grapefruit juice and alcohol can also lead to specific food-drug interactions. In this regard, the growing use of food supplements and functional food requires urgent attention in oral pharmacotherapy. Recently, a new consortium in Understanding Gastrointestinal Absorption-related Processes (UNGAP) was established through COST, a funding organisation of the European Union supporting translational research across Europe. In this review of the UNGAP Working group "Food-Drug Interface", the different mechanisms that can lead to pharmacokinetic food-drug interactions are discussed and summarised from different expert perspectives.
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a uvolňování léčiv $x fyziologie $7 D065546
- 650 _2
- $a interakce mezi potravou a léky $x fyziologie $7 D018565
- 650 _2
- $a gastrointestinální absorpce $x fyziologie $7 D065569
- 650 _2
- $a gastrointestinální trakt $x fyziologie $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intestinální absorpce $7 D007408
- 650 _2
- $a farmakokinetika $7 D010599
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Alcaro, Stefano $u Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale Europa, 88100 Catanzaro, Italy; Net4Science Academic Spinoff, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale Europa, 88100 Catanzaro, Italy.
- 700 1_
- $a Augustijns, Patrick $u Drug Delivery and Disposition, KU Leuven, Herestraat 49, Gasthuisberg, O&N2, Box 921, 3000 Leuven, Belgium.
- 700 1_
- $a Basit, Abdul W $u UCL School of Pharmacy, University College London, 29 - 39 Brunswick Square, London WC1N 1AX, United Kingdom.
- 700 1_
- $a Grimm, Michael $u Department of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, Center of Drug Absorption and Transport, Felix-Hausdorff-Str. 3, D-17487 Greifswald, Germany.
- 700 1_
- $a Hens, Bart $u Drug Delivery and Disposition, KU Leuven, Herestraat 49, Gasthuisberg, O&N2, Box 921, 3000 Leuven, Belgium.
- 700 1_
- $a Hoad, Caroline L $u NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom; Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom.
- 700 1_
- $a Jedamzik, Philipp $u Department of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, Center of Drug Absorption and Transport, Felix-Hausdorff-Str. 3, D-17487 Greifswald, Germany.
- 700 1_
- $a Madla, Christine M $u UCL School of Pharmacy, University College London, 29 - 39 Brunswick Square, London WC1N 1AX, United Kingdom.
- 700 1_
- $a Maliepaard, Marc $u Medicines Evaluation Board in the Netherlands, PKPD Department, Utrecht, the Netherlands.
- 700 1_
- $a Marciani, Luca $u NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
- 700 1_
- $a Maruca, Annalisa $u Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale Europa, 88100 Catanzaro, Italy; Net4Science Academic Spinoff, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale Europa, 88100 Catanzaro, Italy.
- 700 1_
- $a Parrott, Neil $u Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
- 700 1_
- $a Pávek, Petr $u Charles University, Faculty of Pharmacy in Hradec Králové, Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
- 700 1_
- $a Porter, Christopher J H $u Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
- 700 1_
- $a Reppas, Christos $u Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 84 Athens, Greece.
- 700 1_
- $a van Riet-Nales, Diana $u Medicines Evaluation Board in the Netherlands, Quality Department, Utrecht, the Netherlands.
- 700 1_
- $a Rubbens, Jari $u Drug Delivery and Disposition, KU Leuven, Herestraat 49, Gasthuisberg, O&N2, Box 921, 3000 Leuven, Belgium.
- 700 1_
- $a Statelova, Marina $u Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 84 Athens, Greece.
- 700 1_
- $a Trevaskis, Natalie L $u Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
- 700 1_
- $a Valentová, Kateřina $u Laboratory of Biotransformation, Institute of Microbiology, CAS, Vídeňská 1083, CZ-142 20 Prague, Czech Republic.
- 700 1_
- $a Vertzoni, Maria $u Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 84 Athens, Greece.
- 700 1_
- $a Čepo, Dubravka Vitali $u University of Zagreb, Faculty of Pharmacy and Biochemistry, A. Kovačića 1, 10000 Zagreb, Croatia.
- 700 1_
- $a Corsetti, Maura $u NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom. Electronic address: maura.corsetti@nottingham.ac.uk.
- 773 0_
- $w MED00001639 $t European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 134, č. - (2019), s. 31-59
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30974173 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200114083412 $b ABA008
- 999 __
- $a ok $b bmc $g 1483158 $s 1083562
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 134 $c - $d 31-59 $e 20190408 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
- LZP __
- $a Pubmed-20200109
